Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene-Environment Interactions01:20

Gene-Environment Interactions

1.2K
Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
1.2K
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

7.7K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.7K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SATB1 preserves CD4<sup>+</sup> T-cell fidelity and establishes Treg function in antitumor immunity.

Life science alliance·2026
Same author

Satb1 enforces CD4<sup>+</sup> effector T cell lineage stability by repressing Foxp3 via DNA methylation.

Biochemical and biophysical research communications·2026
Same author

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

BMJ open·2026
Same author

Reinvigorating the Cancer-Immunity Cycle With Combined Oncolytic Virus and CAR-T Cell Therapies in Solid Tumors.

Pathology international·2026
Same author

Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling.

Liver cancer·2026
Same author

Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

Cancer immunology research·2026

Related Experiment Video

Updated: Feb 14, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.6K

[Immunosuppressive Environment in Tumors].

Chika Sakai1, Hiroyoshi Nishikawa

  • 1Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 28, 2018
PubMed
Summary

Tumor microenvironment (TME) promotes tumor growth by fostering regulatory T (Treg) cells. These cells, along with altered tumor cell metabolism, create an immunosuppressive environment that hinders effector T (Teff) cell function, leading to poor clinical outcomes.

More Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.5K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.5K

Related Experiment Videos

Last Updated: Feb 14, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.6K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.5K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.5K

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Regulation

Background:

  • Tumor cells create a tumor microenvironment (TME) that supports their growth and progression.
  • The TME often exhibits an immunosuppressive state, characterized by an increased presence of regulatory T (Treg) cells.
  • Treg cells are crucial for maintaining self-tolerance and homeostasis, but their accumulation in tumors is linked to poor clinical outcomes.

Purpose of the Study:

  • To elucidate the role of tumor microenvironment (TME) factors, particularly cellular metabolism, in promoting an immunosuppressive environment.
  • To understand how Treg cells infiltrate, proliferate, and exert suppressive functions within the TME.
  • To investigate the impact of nutrient availability and metabolic byproducts on effector T (Teff) cell function within the TME.

Main Methods:

  • Analysis of Treg cell recruitment, proliferation, and suppressive mechanisms within the TME.
  • Investigation of tumor cell and immune cell metabolism, including glucose and glutamine utilization.
  • Assessment of the effects of nutrient deprivation, lactate accumulation, and adenosine on Teff cell function.

Main Results:

  • Treg cells, through mechanisms like CTLA-4 expression and inhibitory cytokine production, suppress T-cell activation and effector functions.
  • Tumor cell and immune cell metabolism in the TME alters nutrient availability (low glucose and glutamine), favoring Treg cell function over Teff cell activity.
  • High lactate levels and adenosine, byproducts of tumor cell metabolism, further impair Teff cell proliferation and function while enhancing Treg cell suppressive capacity.

Conclusions:

  • The TME, through intricate metabolic reprogramming of tumor and immune cells, creates an environment conducive to Treg cell dominance.
  • This metabolic dysregulation leads to the suppression of Teff cell-mediated anti-tumor immunity, contributing to tumor progression.
  • Targeting metabolic pathways and Treg cell functions within the TME represents a potential therapeutic strategy for cancer treatment.